Exchange: NASDAQ·Updated 04:00 PM EDT
VRCA logo

VRCA Verrica Pharmaceuticals Inc

$3.44
$0.155
(4.31%)
Today
EarningsNov 13
Mkt Cap$61.76M
Vol79,831.00

About VRCA

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
57

Bullish Sentiment

How do you feel about VRCA?

Advertisement|Remove ads.